• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2017 年区域性寡转移疾病放射治疗的进展。

Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017.

机构信息

Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.

Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.

出版信息

J Thorac Oncol. 2018 Apr;13(4):488-496. doi: 10.1016/j.jtho.2018.02.001. Epub 2018 Feb 13.

DOI:10.1016/j.jtho.2018.02.001
PMID:29452269
Abstract

This review highlights key publications and abstracts in the field of radiation oncology for lung cancer in 2017 and attempts to place these in the context of developments for the broader thoracic oncology community.

摘要

这篇综述重点介绍了 2017 年放射肿瘤学领域关于肺癌的重要出版物和摘要，并试图将这些内容置于更广泛的胸肿瘤学领域的发展背景下。

相似文献

1
Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017.2017 年区域性寡转移疾病放射治疗的进展。
J Thorac Oncol. 2018 Apr;13(4):488-496. doi: 10.1016/j.jtho.2018.02.001. Epub 2018 Feb 13.
2
A critical review of recent developments in radiotherapy for non-small cell lung cancer.对非小细胞肺癌放射治疗近期进展的批判性综述。
Radiat Oncol. 2016 Sep 6;11(1):115. doi: 10.1186/s13014-016-0693-8.
3
[Treatment of oligometastatic or oligoprogression cancer].[寡转移或寡进展性癌症的治疗]
Cancer Radiother. 2019 Oct;23(6-7):482-485. doi: 10.1016/j.canrad.2019.07.143. Epub 2019 Sep 5.
4
Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice.寡转移非小细胞肺癌的放射治疗：理论与实践
Cancer J. 2015 Sep-Oct;21(5):404-12. doi: 10.1097/PPO.0000000000000143.
5
Stereotactic radiotherapy in oligometastatic cancer.寡转移癌的立体定向放射治疗。
Chin Clin Oncol. 2017 Sep;6(Suppl 2):S16. doi: 10.21037/cco.2017.06.20.
6
[Stereotactic radiotherapy following chemo-radiotherapy for lymph node metastasis of stage III non-small-cell lung cancer].
Gan To Kagaku Ryoho. 2011 Nov;38(12):2191-3.
7
Stereotactic body radiotherapy for early stage lung cancer-historical developments and future strategies.早期肺癌的立体定向体部放射治疗——历史发展与未来策略
Chin Clin Oncol. 2017 Sep;6(Suppl 2):S20. doi: 10.21037/cco.2017.08.02.
8
Radiation therapy for oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌的放射治疗
Cancer Metastasis Rev. 2015 Jun;34(2):183-93. doi: 10.1007/s10555-015-9559-z.
9
Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.非小细胞肺癌是否存在寡转移状态？文献系统综述。
Lung Cancer. 2013 Nov;82(2):197-203. doi: 10.1016/j.lungcan.2013.07.026. Epub 2013 Aug 20.
10
Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer: Past, Present, and Future.寡转移非小细胞肺癌的放射治疗：过去、现在和未来。
Oncology (Williston Park). 2021 Jun 17;35(6):313-319. doi: 10.46883/ONC.2021.3506.0311.

引用本文的文献

1
Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy.癌症免疫疗法与放疗和/或化疗联合应用：作用机制与临床治疗
MedComm (2020). 2025 Aug 31;6(9):e70346. doi: 10.1002/mco2.70346. eCollection 2025 Sep.
2
A Feasibility Study for Clinical Implementation of hypo fractionated SBRT Program at a Clinic in an LMIC Using Locally Designed Lung Phantom.在中低收入国家一家诊所使用本地设计的肺部体模对低分割立体定向放疗计划进行临床实施的可行性研究。
Adv Radiat Oncol. 2025 Mar 7;10(6):101752. doi: 10.1016/j.adro.2025.101752. eCollection 2025 Jun.
3
Systemic Immune Activation and Responses of Irradiation to Different Metastatic Sites Combined With Immunotherapy in Advanced Non-Small Cell Lung Cancer.
全身免疫激活与放疗对不同转移部位的反应联合免疫治疗晚期非小细胞肺癌。
Front Immunol. 2021 Dec 14;12:803247. doi: 10.3389/fimmu.2021.803247. eCollection 2021.
4
Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study.改良格拉斯哥预后评分对立体定向体部放射治疗的非小细胞肺癌患者预后的预测作用：一项回顾性研究。
J Radiat Res. 2021 May 12;62(3):457-464. doi: 10.1093/jrr/rrab021.
5
SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges.SBRT 联合 PD-1/PD-L1 抑制剂治疗 NSCLC：关注机制、进展和未来挑战。
J Hematol Oncol. 2020 Jul 28;13(1):105. doi: 10.1186/s13045-020-00940-z.
6
Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients.分析 III 期和 IV 期非小细胞肺癌患者达到完全缓解的关键临床特征。
Respir Res. 2019 Nov 21;20(1):263. doi: 10.1186/s12931-019-1235-3.
7
Comparative effectiveness of concurrent chemoradiotherapy versus EGFR-tyrosine kinase inhibitors for the treatment of clinical stage IIIb lung adenocarcinoma patients with mutant EGFR.比较伴化疗同期与 EGFR 酪氨酸激酶抑制剂治疗携带突变型 EGFR 的 IIIb 期肺腺癌患者的疗效。
Thorac Cancer. 2018 Nov;9(11):1398-1405. doi: 10.1111/1759-7714.12847. Epub 2018 Aug 27.